Waypoint Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $872K | Buy |
4,417
+160
| +4% | +$31.6K | 0.19% | 75 |
|
|
2024
Q2 | $730K | Buy |
4,257
+157
| +4% | +$26.9K | 0.18% | 77 |
|
|
2024
Q1 | $747K | Buy |
4,100
+66
| +2% | +$12K | 0.2% | 74 |
|
|
2023
Q4 | $625K | Sell |
4,034
-109
| -3% | -$16.9K | 0.18% | 76 |
|
|
2023
Q3 | $618K | Buy |
4,143
+1,778
| +75% | +$265K | 0.21% | 71 |
|
|
2023
Q2 | $319K | Buy |
2,365
+63
| +3% | +$8.49K | 0.1% | 113 |
|
|
2023
Q1 | $367K | Sell |
2,302
-1
| -0% | -$159 | 0.12% | 100 |
|
|
2022
Q4 | $372K | Buy |
2,303
+11
| +0.5% | +$1.78K | 0.13% | 99 |
|
|
2022
Q3 | $307K | Buy |
2,292
+1
| +0% | +$134 | 0.13% | 92 |
|
|
2022
Q2 | $351K | Sell |
2,291
-40
| -2% | -$6.13K | 0.16% | 84 |
|
|
2022
Q1 | $376K | Sell |
2,331
-63
| -3% | -$10.2K | 0.22% | 80 |
|
|
2021
Q4 | $324K | Buy |
+2,394
| New | +$324K | 0.22% | 70 |
|